ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Stock Analyst Earnings Estimates
EPA:ALOPM - Euronext Paris - Matif - FR001400CM63 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.41M | 3.83M -13.15% | 7.98M 108.36% | 1.494M -81.28% | 2.575M 72.36% | 6.489M 152.00% | 3.914M -39.68% | |
| EBITDA YoY % growth | N/A | N/A | N/A | -9.219M | -7.632M 17.21% | -535.6K 92.98% | -13.787M -2,474.04% | |
| EBIT YoY % growth | -6.16M | -3.73M 39.45% | -1.61M 56.84% | -10.455M -549.35% | -8.745M 16.35% | -8.122M 7.13% | -11.891M -46.42% | |
| Operating Margin | -139.68% | -97.39% | -20.18% | -699.77% | -339.60% | -125.16% | -303.82% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.50 | -0.41 18.37% | -0.37 10.00% | -0.51 -37.50% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |